The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28…
Read More »Cancer
Chinese drugmakers have signed a late-year burst of out-licensing agreements with overseas partners, underlining China’s growing role as a source…
Read More »
Antibody-drug conjugates (ADC), a fast-growing next-generation cancer treatment, have become an investment hotspot due to its potential to become mainstream…
Read More »
Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose…
Read More »
China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand and growth…
Read More »
Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…
Read More »
Clem Burke, the iconic drummer of Blondie, has passed away at the age of 70 following a private battle with…
Read More »
China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »
HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…
Read More »
Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…
Read More »